サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768801

分岐部病変の世界市場

Bifurcation Lesions

出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
分岐部病変の世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

分岐部病変の世界市場は2030年までに36億米ドルに達する

2024年に25億米ドルと推定される分岐部病変の世界市場は、2024～2030年の分析期間にCAGR 6.2%で成長し、2030年には36億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである冠動脈血管は、CAGR 6.1％を記録し、分析期間終了時には20億米ドルに達すると予測されます。末梢血管セグメントの成長率は、分析期間でCAGR 6.3％と推定されます。

米国市場は6億5,780万米ドルと推定、中国はCAGR9.7％で成長予測

米国の分岐部病変市場は、2024年に6億5,780万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 9.7%で推移し、2030年には8億7,270万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3%と4.7%と予測されています。欧州では、ドイツがCAGR 4.3%で成長すると予測されています。

世界の分岐部病変市場- 主要動向と促進要因のまとめ

心血管治療における分岐部病変の複合性とは？

分岐部病変は、インターベンショナル心臓病学において、主動脈が二次的な経路に分岐する動脈分岐部またはその近傍にある閉塞によって生じる、実質的かつ複雑な課題を表しています。このような動脈の枝分かれは血流管理を複雑にし、効果的な治療にはより高度な技術が必要となります。分岐部では、血流を損なわず、合併症のリスクを増大させることなく、主枝と側枝の両方をサポートできるアプローチが必要となるため、このような部位の病変は特に治療が困難です。このような分岐部の解剖学的構造にはプラークが不規則に分布していることが多く、より単純な非分岐病変と比較して、再狭窄（閉塞の再発）の可能性が高くなり、心血管系の有害事象の発生率も高くなります。これらの因子は手技の失敗や長期予後不良のリスクの上昇につながり，正確で個別化された戦略の必要性を強調しています。さらに、分岐部病変では、従来のステントは分岐部特有の構造的要件に適応できないことが多いため、ステント留置手技中に側枝が閉塞する危険性を提示しています。したがって、インターベンショナルカーディオロジストは、病変の解剖学的・病理学的特徴に基づいてシングルステントテクニックかデュアルステントテクニックかを選択しなければならないことが多く、患者ごとに最適なアプローチを特定する複雑な意思決定プロセスに直面しています。

ステント留置術の技術革新は分岐部病変の治療にどのような革命をもたらしたか？

近年、技術の進歩によりステント留置術は著しく改善され、以前は安全性と有効性の両面で大きな課題となっていた分岐部病変に対して、より洗練された正確な解決策が提供されるようになりました。従来のステントは、分岐していないまっすぐな動脈のためにデザインされたものであり、分岐部特有の要求に対して必要とされる構造的汎用性に欠けていました。この限界は、分岐部専用のステントの開発とともに、ダブルキス（DK）クラッシュ法や小突出部付きTステント（TAP）のような高度なステント留置術の開発によって対処されており、これらはいずれも一次動脈の耐久性のある支持を確保しながら側枝閉塞のリスクを減少させることで臨床転帰の改善を示しています。さらに、従来のステントに代わる画期的な方法として生体吸収性血管足場（BVS）が導入されました。このようなデバイスは時間の経過とともに血管内で徐々に溶解するため、血管をより自然な状態に保ち、慢性炎症や再狭窄などの後期合併症のリスクを低下させる可能性があります。さらに、光干渉断層計（OCT）や血管内超音波（IVUS）を含む画像診断技術の進歩は、手技の精度を大幅に向上させています。これらの画像診断装置により、心臓専門医はステント留置中にリアルタイムで調整を行うことができ、留置位置の誤りや不完全な被覆といった技術的ミスの可能性を最小限に抑えることができます。これらの技術革新は、分岐部病変の管理における変革的なシフトを強調するものであり、患者にとってより効果的で、より安全で、高度に個別化された治療法へと向かっています。

なぜ分岐部病変の臨床管理は依然として課題なのか？

かなりの技術的進歩にもかかわらず、分岐部病変の臨床管理は、複雑さを伴い続けています。その主な原因は、これらの病変の解剖学的、動態学的な変化と、患者集団に見られる多様な反応です。分岐部病変の管理における最も根強い課題のひとつは、ステント留置の適切な戦略を決定することにあります。例えば、シングルステントアプローチとデュアルステントアプローチの選択は必ずしも一筋縄ではいかず、病変の位置、プラークの蓄積の程度、患者の全体的な健康状態など、病変の特異的な特徴に左右されることが多いです。DEFINITION IIやBBC ONEのような臨床試験は、複雑な分岐部治療のベストプラクティスに関する洞察を与えてきたが、同時に、患者の人口統計、病変のタイプ、プラークの形態などの要因によって治療成績が大きく異なることも明らかにしています。ステント留置の手技そのものは一般に長くなり、技術的にも困難であり、ステント不適合などの合併症の可能性も高くなります。さらに、このような病変の治療では再狭窄やステント内血栓症のリスクが高いため、しばしば長期間の経過観察が必要となります。二重抗血小板療法（DAPT）のような薬物療法プロトコールはこれらのリスクを軽減するために必要であるが、出血性合併症を増加させる可能性もあり、分岐部病変患者のアフターケアにおいて臨床医が維持しなければならない微妙なバランスを強調しています。このような継続的な課題は、継続的な研究、オーダーメイドの治療プロトコルの開発、より耐久性が高く安全なソリューションを提供できる技術革新の必要性を強調しています。

分岐部病変治療市場の成長の原動力は？

分岐部病変治療市場の成長は、主に技術の進歩、心血管疾患の有病率の上昇、低侵襲処置に対する消費者の需要の増加など、いくつかの重要な要因によって牽引されています。人口の高齢化や、食生活の乱れ、喫煙、座りっぱなしなどの生活習慣に関連した危険因子によって、冠動脈疾患の症例が世界的に増加しており、分岐部のような複雑な病変に対処できる高度な心血管治療に対する需要が高まっています。技術革新はこのような病変に対する治療の選択肢を拡大する上で重要な役割を果たしており、分岐部専用ステント、強化型薬剤溶出ステント、生体吸収性血管スカフォールドは現在、より安全で効果的な治療成績を提供しています。このようなデバイスの出現は、精密画像診断技術とともに、医療機器メーカーによる研究開発への多大な投資を引き寄せており、その結果、分岐部病変特有の要件に合わせた次世代製品の強力なパイプラインが形成されています。その他の特典として、回復時間の短縮、ヘルスケアコストの削減、従来の手術と比較したインターベンショナル手技の全体的な安全性プロファイルなどが挙げられます。このシフトは、インターベンショナル手技の分岐部病変への採用を促進し、患者とヘルスケアプロバイダーの両方から好まれるアプローチとしての地位を確固たるものにしています。最新の技術革新とその臨床的利点に関するヘルスケア専門家と患者の意識の高まりが、この動向をさらに加速させています。さらに、多くの国における規制政策や政府医療費の増加が、こうした先進的な治療法の普及を後押ししており、分岐部病変のインターベンションは心血管市場において急速に拡大する分野となっています。

セグメント

アプリケーション（冠動脈血管、末梢血管）

調査対象企業の例

  • Abbott
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health
  • Johnson& Johnson Services, Inc
  • Medtronic
  • Spectranetics
  • Terumo Medical Corporation

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21324

Global Bifurcation Lesions Market to Reach US$3.6 Billion by 2030

The global market for Bifurcation Lesions estimated at US$2.5 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Coronary Vascular, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Peripheral Vascular segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$657.8 Million While China is Forecast to Grow at 9.7% CAGR

The Bifurcation Lesions market in the U.S. is estimated at US$657.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$872.7 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Bifurcation Lesions Market - Key Trends and Drivers Summarized

What Makes Bifurcation Lesions Complex in Cardiovascular Treatment?

Bifurcation lesions represent a substantial and intricate challenge in interventional cardiology, arising due to blockages located at or near arterial branches where a main artery splits into a secondary pathway. This branching nature of the artery complicates blood flow management, requiring more advanced techniques for effective treatment. Lesions in these locations are particularly difficult to treat because the bifurcation region requires an approach that can support both the main and side branches without compromising blood flow or increasing the risk of complications. The anatomy at these junctions often contains an irregular distribution of plaque, which increases the likelihood of restenosis-a recurrence of blockage-as well as higher rates of adverse cardiovascular events compared to simpler, non-bifurcated lesions. These factors lead to an elevated risk of procedural failure and poor long-term outcomes, which underscores the need for precise and individualized strategies. Additionally, bifurcation lesions present the risk of side branch occlusion during stenting procedures, as traditional stents often fail to adapt to the unique structural requirements of bifurcated areas. Interventional cardiologists, therefore, face a complex decision-making process in identifying the optimal approach for each patient, often having to choose between single-stent or dual-stent techniques based on the specific anatomical and pathological characteristics of the lesion.

How Have Innovations in Stenting Techniques Revolutionized Bifurcation Lesion Treatment?

Over recent years, technological advancements have markedly improved stenting techniques, offering more refined and precise solutions for bifurcation lesions that previously posed substantial challenges in terms of both safety and efficacy. Traditional stents, which were largely designed for straight, non-branching arteries, lacked the structural versatility required for the unique demands of bifurcated regions. This limitation has been addressed with the development of specialized bifurcation stents, as well as advanced stenting techniques like the double kissing (DK) crush method and T-stenting with small protrusion (TAP), both of which have shown improved clinical outcomes by reducing the risk of side branch blockage while ensuring durable support for the primary artery. Additionally, bioresorbable vascular scaffolds (BVS) have been introduced as a groundbreaking alternative to traditional stents; these devices gradually dissolve within the artery over time, potentially leaving the vessel in a more natural state and lowering the risk of late-stage complications such as chronic inflammation or restenosis. Furthermore, advancements in imaging technology, including Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS), have greatly enhanced procedural precision. These imaging modalities allow cardiologists to make real-time adjustments during stent deployment, helping to minimize the likelihood of technical errors such as malapposition or incomplete coverage. Together, these innovations underscore a transformative shift in the management of bifurcation lesions, moving towards more effective, safer, and highly individualized treatment options for patients.

Why Is the Clinical Management of Bifurcation Lesions Still Challenging?

Despite considerable technological progress, the clinical management of bifurcation lesions continues to be fraught with complexities, largely due to the variable anatomy and dynamics of these lesions and the diverse responses seen across patient populations. One of the most persistent challenges in managing bifurcation lesions lies in determining the appropriate strategy for stenting, as each technique carries its own set of risks and potential benefits. The choice between single-stent and dual-stent approaches, for instance, is not always straightforward and often depends on the specific characteristics of the lesion, such as its location, the degree of plaque buildup, and the patient’s overall health condition. Clinical trials, such as DEFINITION II and BBC ONE, have provided insights into the best practices for treating complex bifurcations, yet they also reveal that outcomes can vary significantly depending on factors like patient demographics, lesion type, and plaque morphology. The procedure itself is typically longer and technically demanding, with increased potential for complications such as stent malapposition, which may lead to incomplete coverage or even stent thrombosis. Additionally, managing these lesions often requires long-term follow-up due to the high risk of restenosis and in-stent thrombosis, both of which can compromise the initial treatment success. Post-procedural care is further complicated by pharmacotherapy protocols such as dual antiplatelet therapy (DAPT), which are necessary to mitigate these risks but can also increase bleeding complications, highlighting the delicate balance clinicians must maintain in the aftercare of bifurcation lesion patients. These ongoing challenges emphasize the need for continuous research, the development of tailored treatment protocols, and innovations that can provide more durable and safer solutions for bifurcation lesions.

What Is Driving the Growth of the Bifurcation Lesion Treatment Market?

The growth in the bifurcation lesion treatment market is driven by several key factors, primarily technological advancements, a rising prevalence of cardiovascular diseases, and increasing consumer demand for minimally invasive procedures. The global rise in cases of coronary artery disease, fueled by aging populations and lifestyle-related risk factors such as poor diet, smoking, and sedentary behavior, has generated a growing demand for advanced cardiovascular interventions capable of addressing complex lesions like bifurcations. Technological innovations have played a crucial role in expanding treatment options for these lesions, with dedicated bifurcation stents, enhanced drug-eluting stents, and bioresorbable vascular scaffolds now offering safer and more effective outcomes. The emergence of these devices, alongside precision imaging techniques, has attracted significant investment in research and development from medical device companies, resulting in a robust pipeline of next-generation products tailored to the unique requirements of bifurcation lesions. Additionally, consumer preferences have shifted markedly toward minimally invasive techniques, driven by benefits such as reduced recovery times, lower healthcare costs, and the overall safety profile of interventional procedures compared to traditional surgeries. This shift has fostered greater adoption of interventional techniques for bifurcation lesions, solidifying their place as the preferred approach among both patients and healthcare providers. Rising awareness among healthcare professionals and patients regarding the latest innovations and their clinical advantages has further accelerated this trend. Moreover, supportive regulatory policies and increased government healthcare spending in many countries are facilitating the widespread adoption of these advanced treatment options, helping to make bifurcation lesion intervention a rapidly expanding segment within the cardiovascular market.

SCOPE OF STUDY:

The report analyzes the Bifurcation Lesions market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Coronary Vascular, Peripheral Vascular)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health
  • Johnson& Johnson Services, Inc
  • Medtronic
  • Spectranetics
  • Terumo Medical Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Bifurcation Lesions - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Drives Growth in Bifurcation Lesions Treatment Market
    • Increasing Demand for Minimally Invasive Procedures Fuels Adoption of Advanced Bifurcation Stenting Techniques
    • Here's How Technological Advances in Imaging Improve Precision in Treating Bifurcation Lesions
    • Growing Use of Drug-Eluting Stents Expands Market for Effective Bifurcation Lesion Solutions
    • Rising Focus on Reducing Procedure-Related Complications Supports Innovation in Stent Design
    • Increasing Adoption of Bifurcation-Specific Devices Enhances Success Rates in Complex Lesion Treatment
    • Here's How Dual-Lumen Catheters Improve Access and Control in Bifurcation Lesion Interventions
    • Advancements in Guidewire Technology Improve Navigation and Stability During Lesion Treatment
    • Here's How New Angioplasty Techniques Drive Better Outcomes for Complex Lesion Patients
    • Increasing Investment in Clinical Trials Expands Evidence-Based Treatment Approaches
    • Focus on Patient-Specific Solutions Drives Demand for Customizable Bifurcation Stent Systems
    • Rising Demand for Bioabsorbable Stents Encourages Development of Next-Gen Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bifurcation Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bifurcation Lesions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Bifurcation Lesions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Coronary Vascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Coronary Vascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Coronary Vascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Peripheral Vascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Peripheral Vascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Peripheral Vascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Bifurcation Lesions Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: USA 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: Canada 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • JAPAN
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Japan 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • CHINA
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: China 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • EUROPE
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Bifurcation Lesions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Bifurcation Lesions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Europe 15-Year Perspective for Bifurcation Lesions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • FRANCE
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: France 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • GERMANY
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Germany 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Italy 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: UK 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Spain 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Russia 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Bifurcation Lesions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Bifurcation Lesions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 15-Year Perspective for Bifurcation Lesions by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Australia 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • INDIA
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: India 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: South Korea 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Bifurcation Lesions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Bifurcation Lesions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Latin America 15-Year Perspective for Bifurcation Lesions by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Argentina 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Brazil 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Mexico 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Bifurcation Lesions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Bifurcation Lesions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Middle East 15-Year Perspective for Bifurcation Lesions by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Iran 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Israel 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: UAE 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030
  • AFRICA
    • Bifurcation Lesions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Bifurcation Lesions by Application - Coronary Vascular and Peripheral Vascular Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Africa 15-Year Perspective for Bifurcation Lesions by Application - Percentage Breakdown of Value Sales for Coronary Vascular and Peripheral Vascular for the Years 2015, 2025 & 2030

IV. COMPETITION